Abstract:This meta-analysis was performed to evaluate the relationships between promoter DNA methylation in tumor suppressor gene p16 and gastric carcinogenesis. The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library and CBM databases were searched for relevant articles published before November 1st, 2013 without any language restrictions. Meta-analysis was conducted using the STATA 12.0 software. Crude odds ratios (ORs) with 95 % confidence intervals (95 % CI) were calculated. Forty-seven clinical cohort studies that met all inclusion criteria were included in this meta-analysis. A total of 2,813 gastric cancer (GC) patients were assessed. Our meta-analysis results revealed that the frequencies of p16 promoter methylation in the GC tissues were higher than those of normal and adjacent tissues (Normal: OR = 23.04, 95 % CI = 13.55–39.15, P < 0.001; Adjacent: OR = 4.42, 95 % CI = 1.66–11.76, P = 0.003; respectively). Furthermore, we observed significant associations of p16 promoter methylation with TNM stage, histologic grade, invasive grade, lymph node metastasis of GC (TNM stage: OR = 3.60, 95 % CI: 2.17–5.98, P < 0.001; Histologic grade: OR = 2.63, 95 % CI: 1.55–4.45, P < 0.001; Invasive grade: OR = 3.44, 95 % CI: 1.68–7.06, P = 0.001; Lymph node metastasis: OR = 2.68, 95 % CI: 1.66–4.32, P < 0.001; respectively). However, there were no correlations of p16 promoter methylation with the TNM stage and Helicobacter pylori (HP) infection of GC (Tumor size: OR = 0.76, 95 % CI: 0.14–4.07, P = 0.746; HP infection: OR = 1.31, 95 % CI: 0.75–2.27, P = 0.342; respectively). Our findings provide empirical evidence that p16 promoter methylation may play an important role in gastric carcinogenesis. Thus, p16 promoter methylation may be a promising potential biomarker for the early diagnosis of GC.

Analysis of aberrant methylation of p16 gene promoter in tissue from gastric cancer patients

Correlation of p16 gene methylation with protein expression in gastric cancer and its clinical significance

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

The abnormalities of p16 gene expression and the methylation status of p16 gene promotor in gastric cancer

Methylation of P16 CpG Islands Correlated with Malignant Progression of Gastric Dysplasia in a Nested Case-Control Study

Methylation Of P16 Cpg Islands Associated With Malignant Transformation Of Gastric Dysplasia In A Population-Based Study

RETRACTED ARTICLE: Role of P16 Gene Promoter Methylation in Gastric Carcinogenesis: a Meta-Analysis

Prognostic Significance of Aberrant Gene Methylation in Gastric Cancer.

Aberrant Methylation in CpG Islands of P15 and P16 Tumor Suppressor Genes in Pancreatic Cancer Tissue

Association between p16 methylation and malignant transformation of gastric dysplasia

Correlation Between Suppressor Genes Promoter Hypermethylation and Chemosensitivity of Gastric Cancer

Analysis of Promoter Hypermethylation of P16 Gene in Sera from Non-Small Cell Lung Cancer Patients

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Detection of Multiple Gene Methylation and Expression in Gastric Carcinoma

Promoter Methylation of P16 Associated with Helicobacter Pylori Infection in Precancerous Gastric Lesions: A Population‐based Study

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR

Promoter Hypermethylation of P16 Gene in Pre- and Post-Operative Plasma of Patients with Gastric Adenocarcinoma

Aberrant Methylation Status of SPG20 Promoter in Hepatocellular Carcinoma: A Potential Tumor Metastasis Biomarker.

Correlation Between Methylation of the P16 Promoter and Cervical Cancer Incidence.

Aberrant Methylation of CpG Island in 5'promoter Region of P16 Gene and Its Role in Diagnosis of Pancreatic Cancer

The Biological Significance of Detecting DNA Promoter Hypermethylation by Exfoliated Cells of Gastric Juice in Gastric Cancer